Get started

Supportzones

$IMRNImmuron stock rockets after funding by U.S. DoD of new research agreement Shares of Immuron Ltd. IMRN, +46.18% rocketed 49.6% in active premarket trading Wednesday, after the Australia-based biopharmaceutical company said it received an award of AUD$6.2 million ($4.5 million) from the U.S. Department of Defense to evaluate Travelan for military use. Trading volume spiked to 1.3 million shares, compared with the full-day average of about 60,500. The award is aimed at testing the efficacy of a single larger dose regimen of Travelan for the treatment of moderate to severe diarrhea upon challenge with enterotoxigenic Escherichia coli (ETEC). "This new project expands our clinical development program and represents the first of several significant clinical trials which the Company expects to undertake with the US Military in 2022," said Immuron Chief Executive JErry Kanellos. "The new funding is testament to the value proposition our hyperimmune bovine polyclonal colostrum technology offers to benefit the US Military as well as the civilian international travelling population." The stock has tumbled 30.1% over the past three months while the iShares Biotechnology ETF IBB, -1.11% has declined 7.2% and the S&P 500 SPX, +0.28% has gained 8.3%.
NASDAQ:IMRNLong
by BADQOMOCAWGOWLD
1
BTC 52k or 30k?BTC is and has been in a bearish trend. I went ahead and mapped out KEY support and resistance zones with the amount of % shown if it decides to move up or down. Since it's currently at support, I can expect to see a bounce here. If the bulls are strong enough, we can see a push to the next resistance, which is around the 52k area. If the bearish pressure continues, then we can expect a move to the 30k area! lets keep it simple and see. Don't trade with what you're not willing to lose. Safe Trading, Calculate Your Risk/Reward & Collect! Love it or hate it, hit that thumbs up and share your thoughts! This is not financial advice. This is for educational purposes only.
BITFINEX:BTCUSD
by rnaofs
LONG on NZD/CADThis pair has a descending triangle and is currently back at the support zone it has not be able to break from previous attempts in the past. On the lower timeframes (1hr, etc) there is a bounce off of the golden zone of Fibonacci and I am looking for this pair to continue pushing up. Here is the play I will be taking on this pair: PAIR = NZD/CAD ORDER TYPE = MARKET BUY NOW LOT SIZE = Micro lot (0.01) (0.02) ENTRY PRICE = 0.86595 STOP LOSS = 0.86120 - 54 PIPS TAKE PROFIT = 0.87614 - 95 PIPS
Long
by BBIDF
ETH Looking Extra Bearish!ETH has clearly broken out of the parallel channel shown and is looking more bearish as the days go by. I've marked on the chart the next support zones to pay attention to. These zones would be the best areas to look to go long. You can also consider a short but with a tight stop in case of a bullish push from the whales. Let's see how this will play out in the coming days. Do you think inflation is playing a role here? Do you think there will ever be another bear market... if so are we currently in one? Let me know your thoughts below. Love it or hate it, hit that thumbs up and share your thoughts! Don't trade with what you're not willing to lose. Safe Trading, Calculate Your Risk/Reward & Collect! This is not financial advice.
by rnaofs
That looks like great support to me... Many touches and support at this price from last consolidation, always wait for confirmation and then attack. We can see the daily MACD giving us a good entry after this consolidation over the support line, last time price was at this levels and the MACD gave us this signal ADA when nuts doing over 180% in 40 days. We always try to look for the trap in our own analysis, as we had a fakeout MACD signal last october, and, although it wasn't at the same levels or resistance, it might be our bear signal if it develops the same. You can start DCA'ing from this resistance or wait for confirmation if breaks from this reversal pattern "Don't trade withouth an strategy"
ALong
by CriptoJoe
$PETV Support and ResistancePetVivo shares are trading higher after ThinkEquity initiated coverage on the stock with a Buy rating and a $7 price target. PetVivo Holdings, Inc., a veterinary biotech and biomedical device company, engages in the licensing and commercializing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Kush, a veterinarian-administered joint injection for the treatment of osteoarthritis and lameness in dogs and horses. The company's pipeline products include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Minneapolis, Minnesota.
PLong
by BADQOMOCAWGOWLD
$ARDX Support and ResistanceArdelyx shares are trading higher after Ladenburg Thalmann upgraded the stock from Neutral to Buy and announced a $6 price target. Also, Citigroup maintained a Buy rating and raised its price target from $7 to $13. Ardelyx, Inc., a biopharmaceutical company, develops and sells medicines for the treatment of kidney and cardiorenal diseases in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase 3 clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase 3 clinical trial for the treatment of hyperphosphatemia in end-stage renal disease patients on dialysis. It also develops RDX013, a small molecule potassium secretagogue program that is in Phase 2 clinical trial for the treatment of patients with hyperkalemia; and RDX020, a small molecule program for the treatment of metabolic acidosis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Fremont, California.
NASDAQ:ARDXLong
by BADQOMOCAWGOWLD
$VYNE Support and ResistanceHC Wainwright & Co. Assumes VYNE Therapeutics at Buy, Announces Price Target of $7 VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. The company offers AMZEEQ, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older; and ZILXI for the treatment of inflammation lesions of papulopustular rosacea in adults. It is also developing FCD105, a topical combination foam that has completed Phase II clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in preclinical trial for the treatment of mild-to-moderate atopic dermatitis. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey.
NASDAQ:VYNELong
by BADQOMOCAWGOWLD
XAUUSD Trend analysis OANDA:XAUUSD Bullish Indications 1- Formation of HH & HL 2- Inverted hammer followed by big Green Candle 3- Major monthly Support zone around 1780 4- 4H trendline support 5- support at 0.786 Fib level 6- Double bottom 7- Confluence of Horizontal support + Fib Level + Trendline bounce 8- For last 7 years, December is green for 5 years, 1 year is neutral and 1 is little red. So I am long biased. Even if Gold continues downward trend, it may show bounce from major monthly support area and if bears appear to be much powerful than act according to plan B otherwise plan A will be intact. Both plans are mentioned on chart Please comment for any suggestion, follow and support if you like the idea. Thanks and good luck.
OANDA:XAUUSDLong
by yousufrz
BTC DAILY EMA CORRECTIONS + SUPPORT ZONE ANALYSISMacro support zones come from the WEEKLY chart Three outlooks for the BTC daily chart! Green Outlook 1) Bullish continuation of trend with a future pullback into the upper macro support zone. Red Outlook 2) A healthy bearish daily correction to the 25 & possibly wicking-off 50 EMA if volatile. This appears to be the logical observation, so I have labelled this as a short-term shorting analysis. Dark Red Outlook 3) Very bearish correction continues to the micro liquidity zone (41 - 44.5k estimated) ALL CONTENT IS EDUCATIONAL. NOT FINANCIAL ADVICE. DO YOUR OWN RESEARCH.
Short
by saerinox
$TEL : SHORT-MID TERM TARGETS (1-4H)Telcoin possibly approaching a decisive movement! Green bullish outlook: Push out of descending channel, successful retest off upper descending channel line, push past $0.02 then retest to confirm price breakout at the support zone (purple box), followed by a strong push to $0.03 (green dotted line) Yellow corrective outlook: Falling out of the support zone retesting at the $0.15 mark, then returning to and/or the lower ascending trend line Red bearish outlook: Failing the lower ascending trend line, with a bounce off the 21st July red wick (red dotted line) NOT FINANCIAL ADVICE, DO YOUR OWN RESEARCH, EDUCATIONAL PURPOSES ONLY
by saerinox